The m-chlorophenylpiperazine test in cluster headache and migraine: A study on central serotoninergic activity

M. Leone, A. Attanasio, D. Croci, G. Libro, L. Grazzi, D. D'Amico, A. Nespoloand, G. Bussone

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Cerebral serotoninergic system play a key role in pain modulation and cerebrovascular responses and it has been proposed to be involved in the pathogenesis of migraine and duster headache (CH). m-Chlorophenylpiperazine (m-CPP), a cerebral serotoninergic agonist, induces the release of both cortisol and PRL and we employed it to investigate central serotoninergic system in migraine and CH. Low back pain patients and healthy subjects were the control groups. Forty-five patients with episodic CH headache were studied: 23 were in cluster period and 12 in remission; 11 were migraine without aura sufferers, 6 had low back pain and 17 were healthy subjects. A single oral dose of m-CPP, 0.5 mg/Kg, was given. PRL and cortisol delta maxima (delta maximum = maximum response - baseline level at time O/ baseline level at time 0) were evaluated in each patient and mean values compared. Reduced cortisol (P=0.04) and increased PRL (P=0.03) delta maxima were observed in cluster period CH patients and reduced cortisol (P=0.04) and PRL (P=0.01) delta maxima were observed in CH patients during remission compared to controls. This study suggest impaired central serotoninergic function in cluster headache.

Original languageEnglish
Pages (from-to)46
Number of pages1
JournalItalian Journal of Neurological Sciences
Volume18
Issue number4
Publication statusPublished - 1997

Fingerprint

Cluster Headache
Migraine Disorders
Hydrocortisone
Low Back Pain
Healthy Volunteers
Migraine without Aura
Headache
1-(3-chlorophenyl)piperazine
Pain
Control Groups

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Cite this

The m-chlorophenylpiperazine test in cluster headache and migraine : A study on central serotoninergic activity. / Leone, M.; Attanasio, A.; Croci, D.; Libro, G.; Grazzi, L.; D'Amico, D.; Nespoloand, A.; Bussone, G.

In: Italian Journal of Neurological Sciences, Vol. 18, No. 4, 1997, p. 46.

Research output: Contribution to journalArticle

@article{8b64eb9a4bb44000b49bcfd784de6abd,
title = "The m-chlorophenylpiperazine test in cluster headache and migraine: A study on central serotoninergic activity",
abstract = "Cerebral serotoninergic system play a key role in pain modulation and cerebrovascular responses and it has been proposed to be involved in the pathogenesis of migraine and duster headache (CH). m-Chlorophenylpiperazine (m-CPP), a cerebral serotoninergic agonist, induces the release of both cortisol and PRL and we employed it to investigate central serotoninergic system in migraine and CH. Low back pain patients and healthy subjects were the control groups. Forty-five patients with episodic CH headache were studied: 23 were in cluster period and 12 in remission; 11 were migraine without aura sufferers, 6 had low back pain and 17 were healthy subjects. A single oral dose of m-CPP, 0.5 mg/Kg, was given. PRL and cortisol delta maxima (delta maximum = maximum response - baseline level at time O/ baseline level at time 0) were evaluated in each patient and mean values compared. Reduced cortisol (P=0.04) and increased PRL (P=0.03) delta maxima were observed in cluster period CH patients and reduced cortisol (P=0.04) and PRL (P=0.01) delta maxima were observed in CH patients during remission compared to controls. This study suggest impaired central serotoninergic function in cluster headache.",
author = "M. Leone and A. Attanasio and D. Croci and G. Libro and L. Grazzi and D. D'Amico and A. Nespoloand and G. Bussone",
year = "1997",
language = "English",
volume = "18",
pages = "46",
journal = "Italian Journal of Neurological Sciences",
issn = "0392-0461",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - The m-chlorophenylpiperazine test in cluster headache and migraine

T2 - A study on central serotoninergic activity

AU - Leone, M.

AU - Attanasio, A.

AU - Croci, D.

AU - Libro, G.

AU - Grazzi, L.

AU - D'Amico, D.

AU - Nespoloand, A.

AU - Bussone, G.

PY - 1997

Y1 - 1997

N2 - Cerebral serotoninergic system play a key role in pain modulation and cerebrovascular responses and it has been proposed to be involved in the pathogenesis of migraine and duster headache (CH). m-Chlorophenylpiperazine (m-CPP), a cerebral serotoninergic agonist, induces the release of both cortisol and PRL and we employed it to investigate central serotoninergic system in migraine and CH. Low back pain patients and healthy subjects were the control groups. Forty-five patients with episodic CH headache were studied: 23 were in cluster period and 12 in remission; 11 were migraine without aura sufferers, 6 had low back pain and 17 were healthy subjects. A single oral dose of m-CPP, 0.5 mg/Kg, was given. PRL and cortisol delta maxima (delta maximum = maximum response - baseline level at time O/ baseline level at time 0) were evaluated in each patient and mean values compared. Reduced cortisol (P=0.04) and increased PRL (P=0.03) delta maxima were observed in cluster period CH patients and reduced cortisol (P=0.04) and PRL (P=0.01) delta maxima were observed in CH patients during remission compared to controls. This study suggest impaired central serotoninergic function in cluster headache.

AB - Cerebral serotoninergic system play a key role in pain modulation and cerebrovascular responses and it has been proposed to be involved in the pathogenesis of migraine and duster headache (CH). m-Chlorophenylpiperazine (m-CPP), a cerebral serotoninergic agonist, induces the release of both cortisol and PRL and we employed it to investigate central serotoninergic system in migraine and CH. Low back pain patients and healthy subjects were the control groups. Forty-five patients with episodic CH headache were studied: 23 were in cluster period and 12 in remission; 11 were migraine without aura sufferers, 6 had low back pain and 17 were healthy subjects. A single oral dose of m-CPP, 0.5 mg/Kg, was given. PRL and cortisol delta maxima (delta maximum = maximum response - baseline level at time O/ baseline level at time 0) were evaluated in each patient and mean values compared. Reduced cortisol (P=0.04) and increased PRL (P=0.03) delta maxima were observed in cluster period CH patients and reduced cortisol (P=0.04) and PRL (P=0.01) delta maxima were observed in CH patients during remission compared to controls. This study suggest impaired central serotoninergic function in cluster headache.

UR - http://www.scopus.com/inward/record.url?scp=7344232216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7344232216&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:7344232216

VL - 18

SP - 46

JO - Italian Journal of Neurological Sciences

JF - Italian Journal of Neurological Sciences

SN - 0392-0461

IS - 4

ER -